Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Can dietary and physical activity modifications reduce breast density in postmenopausal women? The DAMA study, a randomized intervention trial in Italy.

Masala G, Assedi M, Sera F, Ermini I, Occhini D, Castaldo M, Pierpaoli E, Caini S, Bendinelli B, Ambrogetti D, Palli D.

Cancer Epidemiol Biomarkers Prev. 2018 Aug 1. pii: cebp.0468.2018. doi: 10.1158/1055-9965.EPI-18-0468. [Epub ahead of print]

PMID:
30068518
2.

Physical activity and blood pressure in 10,000 Mediterranean adults: The EPIC-Florence cohort.

Masala G, Bendinelli B, Occhini D, Bruno RM, Caini S, Saieva C, Ungar A, Ghiadoni L, Palli D.

Nutr Metab Cardiovasc Dis. 2017 Aug;27(8):670-678. doi: 10.1016/j.numecd.2017.06.003. Epub 2017 Jun 15.

PMID:
28755806
3.

Low back pain in healthy postmenopausal women and the effect of physical activity: A secondary analysis in a randomized trial.

Marini M, Bendinelli B, Assedi M, Occhini D, Castaldo M, Fabiano J, Petranelli M, Migliolo M, Monaci M, Masala G.

PLoS One. 2017 May 10;12(5):e0177370. doi: 10.1371/journal.pone.0177370. eCollection 2017.

4.

Up to one-third of breast cancer cases in post-menopausal Mediterranean women might be avoided by modifying lifestyle habits: the EPIC Italy study.

Masala G, Bendinelli B, Assedi M, Occhini D, Zanna I, Sieri S, Agnoli C, Sacerdote C, Ricceri F, Mattiello A, Panico S, Tumino R, Frasca G, Saieva C, Palli D.

Breast Cancer Res Treat. 2017 Jan;161(2):311-320. doi: 10.1007/s10549-016-4047-x. Epub 2016 Nov 10.

PMID:
27832394
5.

The DAMA trial: a diet and physical activity intervention trial to reduce mammographic breast density in postmenopausal women in Tuscany, Italy. Study protocol and baseline characteristics.

Masala G, Assedi M, Caini S, Ermini I, Occhini D, Castaldo M, Bendinelli B, Zagni D, Tanzini D, Saieva C, Ambrogetti D, Palli D.

Tumori. 2014 Jul-Aug;100(4):377-85. doi: 10.1700/1636.17890.

PMID:
25296586
6.

Glycemic index, glycemic load and mammographic breast density: the EPIC Florence longitudinal study.

Masala G, Assedi M, Bendinelli B, Ermini I, Occhini D, Sieri S, Brighenti F, Del Turco MR, Ambrogetti D, Palli D.

PLoS One. 2013 Aug 7;8(8):e70943. doi: 10.1371/journal.pone.0070943. eCollection 2013.

7.

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.

Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, di Grazia C, Frassoni F, Bacigalupo A, Viscoli C.

Biol Blood Marrow Transplant. 2009 Jan;15(1):47-53. doi: 10.1016/j.bbmt.2008.10.024.

8.

Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.

Perfetti P, Carlier P, Strada P, Gualandi F, Occhini D, Van Lint MT, Ibatici A, Lamparelli T, Bruno B, Raiola AM, Dominietto A, Di Grazia C, Bregante S, Zia S, Ferrari GM, Stura P, Pogliani E, Bacigalupo A.

Bone Marrow Transplant. 2008 Nov;42(9):609-17. doi: 10.1038/bmt.2008.221. Epub 2008 Jul 28.

PMID:
18660840
9.

Thiotepa-based reduced intensity conditioning regimen: a 10 year follow up.

Bacigalupo A, Raiola AM, Lamparelli T, Gualandi F, Occhini D, Bregante S, Ibatici A, di Grazia C, Dominietto A, Bruno B, Van Lint MT, Frassoni F.

Bone Marrow Transplant. 2007 Dec;40(11):1091-3. Epub 2007 Oct 1. No abstract available.

PMID:
17906704
10.

Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant.

Vicente D, Lamparelli T, Gualandi F, Occhini D, Raiola AM, Ibatici A, Van Lint MT, Gobbi M, Miglino M, Clavio M, Risso M, Frassoni F, Bacigalupo A.

Bone Marrow Transplant. 2007 Aug;40(4):349-54. Epub 2007 Jun 25.

PMID:
17589537
11.

Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome.

Bacigalupo A, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, Ibatici A, di Grazia C, Dominietto A, Piaggio G, Podesta M, Bruno B, Lombardi A, Frassoni F, Viscoli C, Sacchi N, Van Lint MT.

Bone Marrow Transplant. 2007 Mar;39(6):341-6. Epub 2007 Feb 5.

PMID:
17277788
12.

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Marmont AM, Gualandi F, Occhini D, Morandi F, Ferretti E, Pezzolo A, Strada P, Ravetti JL, Pistoia V, Falanga A, Bacigalupo A.

Autoimmunity. 2006 Sep;39(6):505-11.

PMID:
17060030
13.

Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.

Larocca A, Piaggio G, Podestà M, Pitto A, Bruno B, Di Grazia C, Gualandi F, Occhini D, Raiola AM, Dominietto A, Bregante S, Lamparelli T, Tedone E, Oneto R, Frassoni F, Van Lint MT, Pogliani E, Bacigalupo A.

Haematologica. 2006 Jul;91(7):935-40.

14.

Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.

Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E, Piaggio G, Podesta M, Bruno B, Oneto R, Lombardi A, Frassoni F, Rolla D, Rollandi G, Viscoli C, Ferro C, Garbarino L, Van Lint MT.

Haematologica. 2004 Oct;89(10):1238-47.

15.

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

Raiola AM, Van Lint MT, Valbonesi M, Lamparelli T, Gualandi F, Occhini D, Bregante S, di Grazia C, Dominietto A, Soracco M, Romagnani C, Vassallo F, Casini M, Bruno B, Frassoni F, Bacigalupo A.

Bone Marrow Transplant. 2003 Apr;31(8):687-93.

PMID:
12692609
16.

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants.

Bacigalupo A, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Bruno B, Galbusera V, Frassoni F, Podesta M, Tedone E, Occhini D, Van Lint MT.

Biol Blood Marrow Transplant. 2002;8(12):656-61.

PMID:
12523577
17.

Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.

Bicigalupo A, Lamparelli T, Gualandi F, Bregante S, Raiola A, di Grazia C, Dominietto A, Romagnani C, Occhini D, Frassoni F, van Lint MT.

Blood. 2001 Nov 15;98(10):3174-5. No abstract available.

18.

Acute intravascular hemolysis in two patients transfused with dry-platelet units obtained from the same ABO incompatible donor.

Valbonesi M, De Luigi MC, Lercari G, Florio G, Bruni R, Van Lint MT, Occhini D.

Int J Artif Organs. 2000 Sep;23(9):642-6.

PMID:
11059888
19.

Quality of life in 244 recipients of allogeneic bone marrow transplantation.

Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Frassoni F, Bacigalupo A.

Br J Haematol. 2000 Sep;110(3):614-9.

PMID:
10997973
20.

Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin.

Bacigalupo A, Oneto R, Bruno B, Soracco M, Lamparelli T, Gualandi F, Occhini D, Raiola A, Mordini N, Berisso G, Bregante S, Dini G, Lombardi A, Lint MV, Brand R.

Bone Marrow Transplant. 1999 Sep;24(6):653-9.

21.

Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.

Carella AM, Lerma E, Corsetti MT, Dejana A, Basta P, Vassallo F, Abate M, Soracco M, Benvenuto F, Figari O, Podestá M, Piaggio G, Ferrara R, Sessarego M, Parodi C, Pizzuti M, Rubagotti A, Occhini D, Frassoni F.

Blood. 1999 Mar 1;93(5):1534-9.

22.

Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.

Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Bregante S, Berisso G, Mordini N, Incagliato M, Fugazza G, Sessarego M, Bacigalupo A.

Haematologica. 1998 Oct;83(10):896-903.

23.

Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura.

Marmont AM, van Lint MT, Occhini D, Lamparelli T, Bacigalupo A.

Bone Marrow Transplant. 1998 Oct;22(8):827-8.

24.

Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study.

Moretti S, Zikos P, Van Lint MT, Tedone E, Occhini D, Gualandi F, Lamparelli T, Mordini N, Berisso G, Bregante S, Bruno B, Bacigalupo A.

Bone Marrow Transplant. 1998 Jul;22(2):175-80.

25.

Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.

Zikos P, Van Lint MT, Frassoni F, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, De Stefano F, Soracco M, Vitale V, Bacigalupo A.

Blood. 1998 May 1;91(9):3503-8.

26.

Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.

Bacigalupo A, Zikos P, Van Lint MT, Valbonesi M, Lamparelli T, Gualandi F, Occhini D, Mordini N, Bregante S, Berisso G, Vitale V, Sessarego M, Marmont AM.

Exp Hematol. 1998 May;26(5):409-14.

PMID:
9590657
27.

A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).

Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Mordini N, Berisso G, Bregante S, Bacigalupo A.

Haematologica. 1998 Feb;83(2):132-7.

28.

Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.

Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.

Bone Marrow Transplant. 1997 Dec;20(12):1057-62.

29.

Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications.

Bacigalupo A, Mordini N, Pitto A, Piaggio G, Podestà M, Benvenuto F, van Lint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Figari O, Soracco M, Vassallo F, De Stefano G.

Br J Haematol. 1997 Sep;98(3):760-6.

PMID:
9332336
30.

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.

Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, Lamparelli T, Occhini D, Mordini N, Bregante S, Figari O, Benvenuto F, Sessarego M, Fugazza G, Carlier P, Valbonesi M.

Bone Marrow Transplant. 1997 May;19(9):927-32.

31.

Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).

Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Moro F, Trespi G, Occhini D, Gualandi F, Lamparelli T, Marmont AM.

Bone Marrow Transplant. 1996 Nov;18 Suppl 2:110-4.

PMID:
8932810
32.

Cytogenetic abnormalities in patients with severe aplastic anemia.

Mikhailova N, Sessarego M, Fugazza G, Caimo A, De Filippi S, van Lint MT, Bregante S, Valeriani A, Mordini N, Lamparelli T, Gualandi F, Occhini D, Bacigalupo A.

Haematologica. 1996 Sep-Oct;81(5):418-22.

33.

Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.

Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Trespi G, Occhini D, Gualandi F, Lamparelli T, Marmont AM.

Transplantation. 1996 Aug 15;62(3):376-80.

PMID:
8779686
34.

Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia.

Bacigalupo A, Van Lint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Valeriani A, Piaggio G, Pitto A, Benvenuto F, Figari O, De Stefano G, Caimo A, Sessarego M.

Blood. 1996 Jul 1;88(1):353-7.

35.

Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.

Carella AM, Prencipe E, Pungolino E, Lerma E, Frassoni F, Rossi E, Giordano D, Occhini D, Gatti AM, Bruni R, Spriano M, Nati S, Pierluigi D, Congiu M, Vimercati R, Ravetti JL, Federico M.

Leuk Lymphoma. 1996 Mar;21(1-2):63-70.

PMID:
8907271
36.

CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality.

Bacigalupo A, Tedone E, Isaza A, Soracco M, Van Lint MT, Sanna A, Frassoni F, Occhini D, Gualandi F, Lamparelli T, et al.

Bone Marrow Transplant. 1995 Jul;16(1):155-61.

PMID:
7581116
37.

CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections.

Bacigalupo A, Tedone E, Van Lint MT, Trespi G, Lonngren M, Sanna MA, Moro F, Frassoni F, Occhini D, Gualandi F, et al.

Bone Marrow Transplant. 1994 Jun;13(6):783-8.

PMID:
7920315
38.

Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.

Bacigalupo A, van Lint MT, Tedone E, Moro F, Sanna MA, Longren M, Trespi G, Frassoni F, Occhini D, Gualandi F, et al.

Bone Marrow Transplant. 1994 Jun;13(6):753-8.

PMID:
7920310
39.

Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.

Fagioli F, Bacigalupo A, Frassoni F, Van Lint MT, Occhini D, Gualandi F, Lamparelli T, Clavio M, Vitale V, Sogno G, et al.

Bone Marrow Transplant. 1994 Mar;13(3):247-52.

PMID:
8199567
40.

Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score).

Bacigalupo A, Gualandi F, Van Lint MT, Sessarego M, Frassoni F, Occhini D, Lamparelli T, Oneto R, Vitale V, Corvo R, et al.

Bone Marrow Transplant. 1993 Nov;12(5):443-8.

PMID:
8298554
41.

CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.

Bacigalupo A, Tedone E, Sanna MA, Moro F, Van Lint MT, Grazi G, Balestreri M, Frassoni F, Occhini D, Gualandi F, et al.

Haematologica. 1992 Nov-Dec;77(6):507-13.

PMID:
1337746
42.

Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patients.

Carella AM, Frassoni F, van Lint MT, Gualandi F, Occhini D, Carlier P, Pollicardo N, Pungolino E, Fagioli F, Santini G, et al.

Ann Hematol. 1992 Mar;64(3):128-31.

PMID:
1571408
43.

Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.

Carella AM, Carlier P, Congiu A, Occhini D, Nati S, Santini G, Pierluigi D, Giordano D, Bacigalupo A, Damasio E.

Bone Marrow Transplant. 1991 Aug;8(2):99-103.

PMID:
1718517
44.

Severe aplastic anemia (SAA): response to cyclosporin A (CyA) in vivo and in vitro.

Tong J, Bacigalupo A, Piaggio G, Figari O, van Lint MT, Occhini D, Lamparelli T, Gualandi F, Marmont AM.

Eur J Haematol. 1991 Apr;46(4):212-6.

PMID:
2015876
45.

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.

Bacigalupo A, Van Lint MT, Occhini D, Gualandi F, Lamparelli T, Sogno G, Tedone E, Frassoni F, Tong J, Marmont AM.

Blood. 1991 Apr 1;77(7):1423-8.

46.

Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report.

Carella Am, Carlier P, Congiu A, Occhini D, Meloni G, Anselmo AP, Mandelli F, Mazza P, Tura S, Mangoni L, et al.

Leukemia. 1991;5 Suppl 1:68-71.

PMID:
1890870
47.

The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.

Frassoni F, Bacigalupo A, Sessarego M, Gualandi F, Lamparelli T, Van Lint MT, Occhini D, Corvò R, Scarpati D, Vitale V, et al.

Bone Marrow Transplant. 1991;7 Suppl 2:130. No abstract available.

PMID:
1878675
48.

Factors influencing remission post-BMT in patients with acute and chronic leukemia prepared with cyclophosphamide and total body irradiation (TBI).

Bacigalupo A, Van Lint MT, Frassoni F, Occhini D, Gualandi F, Lamparelli T, Sogno G, Tedone E, Frassoni F, Tong J, et al.

Bone Marrow Transplant. 1991;7 Suppl 3:62-3. Review. No abstract available.

PMID:
1855091
49.

Late complications of allogeneic bone marrow transplantation.

Bacigalupo A, Van Lint MT, Frassoni F, Occhini D, Gualandi F, Lamparelli T, Marmont AM.

Med Oncol Tumor Pharmacother. 1991;8(4):261-3.

PMID:
1820492
50.

Cyclosporin-induced hypertriglyceridemia with prompt response to plasma exchange therapy.

Valbonesi M, Occhini D, Frisoni R, Malfanti L, Capra C, Gualandi F.

J Clin Apher. 1991;6(3):158-60.

PMID:
1787133

Supplemental Content

Loading ...
Support Center